Clin2
NCT07181681Possibly a fitRecruiting

Study of BG-C0902 for advanced solid tumors

Solid TumorsAdvanced Solid Tumor

Part of Cancer clinical trials.

This trial tests a new drug, BG-C0902, alone or with other treatments, for people with advanced solid tumors that have not responded to standard therapies. The goal is to see if it is safe and effective.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
63 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You have an advanced solid tumor that has spread or cannot be removed with surgery, and standard treatments are not working or available.
  • You can provide a sample of your tumor tissue from a past biopsy or agree to have a new biopsy.
  • You have at least one measurable tumor (can be seen on scans).
  • You are up and about and able to take care of yourself (ECOG score 0 or 1).
  • Your blood and organ function tests are within acceptable ranges.
  • If you are able to become pregnant or father a child, you agree to use highly effective birth control during the study and for several months after.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06625593Recruiting· Phase 1
Study of BG-C137 for advanced solid tumors

This trial tests a new drug called BG-C137 for people with advanced solid tumors that have stopped responding to other treatments. The drug targets a protein called FGFR2b found on some cancer cells, aiming to deliver a therapy directly to the tumor.

Los Angeles, California
NCT07414836Recruiting· Phase 1
First test of new drug BG-C0979 for advanced solid tumors

This study tests a new drug called BG-C0979 for advanced solid tumors that have not responded to standard treatments. It may be given alone or with other therapies to see if it can shrink tumors or slow cancer growth.

St Louis, Missouri
NCT06233942Recruiting· Phase 1
Testing a new drug for advanced solid tumors

This early-phase trial tests a new drug called BG-C9074, either alone or with other cancer treatments, for people with certain advanced solid tumors that have not responded to standard therapy. The goal is to see if it is safe and effective.

Los Angeles, California
NCT06598800Recruiting· Phase 1
Study of BG-T187 alone or with other drugs for advanced solid tumors

This trial tests a new treatment, BG-T187, given alone or with other medicines for people with advanced solid tumors that have spread or cannot be removed. It is for those who have already tried other treatments.

Hackensack, New Jersey
NCT07226349Recruiting· Phase 1
Study of a new drug for advanced solid tumors

This trial tests a new drug, BG-75098, alone or with other treatments, for adults with advanced solid tumors that have spread or cannot be removed. It may be an option if you have already tried standard treatments or if they are not suitable for you.

Birmingham, Alabama
NCT07222267Recruiting· Phase 1
Study of BG-75202 for advanced solid tumors

This trial tests a new drug called BG-75202, alone or with other drugs, for people with advanced breast cancer or other solid tumors that have stopped responding to standard treatments. It may offer a new option when other treatments have failed.

Birmingham, Alabama

Hear when a new Advanced Solid Tumor trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.